Paul Kwon

2019

In 2019, Paul Kwon earned a total compensation of $892.9K as Former Chief Scientific Officer at VYNE Therapeutics.

Compensation breakdown

Bonus$153,264
Salary$412,000
Stock Awards$327,624
Total$892,888

Kwon received $412K in salary, accounting for 46% of the total pay in 2019.

Kwon also received $153.3K in bonus and $327.6K in stock awards.

Rankings

In 2019, Paul Kwon's compensation ranked 9,786th out of 13,971 executives tracked by ExecPay. In other words, Kwon earned more than 30.0% of executives.

ClassificationRankingPercentile
All
9,786
out of 13,971
30th
Division
Manufacturing
3,944
out of 5,695
31st
Major group
Chemicals And Allied Products
1,502
out of 2,194
32nd
Industry group
Drugs
1,284
out of 1,880
32nd
Industry
Pharmaceutical Preparations
952
out of 1,392
32nd
Source: SEC filing on June 22, 2020.

Kwon's colleagues

We found two more compensation records of executives who worked with Paul Kwon at VYNE Therapeutics in 2019.

2019

Steven Basta

VYNE Therapeutics

Chief Executive Officer

2019

Kristine Ball

VYNE Therapeutics

Chief Financial Officer

News

You may also like